Q-linea AB (FRA:3F80) Total Operating Expense: kr158.48 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3F80 Q-linea AB FRA:3F80
60 GF Score
Price kr1.76
GF Value kr1.69
! 3 Warning Signs
View Full Analysis

What is Q-linea AB Total Operating Expense?

Q-linea AB FRA:3F80 +10.34% 60 Total Operating Expense is kr158.48 Mil as of Jun. 2026. GuruFocus rates FRA:3F80 with a GF Score™ of 60/100 and a GF Value™ of kr1.69. The stock has 3 warning signs investors should review.

Q-linea AB's Total Operating Expense for the three months ended in Jun. 2026 was kr35.84 Mil. Q-linea AB's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was kr158.48 Mil.

Q-linea AB Total Operating Expense Related Terms

Q-linea AB Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Q-linea AB's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-linea AB Total Operating Expense Chart

Q-linea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 206.74 241.48 231.73 202.56 174.13

Q-linea AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.84 39.89 46.89 35.85 35.84
FRA:3F80
60GF Score
Q-linea AB FRA:3F80
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-linea AB Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr158.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of kr158.48 Mil mean?
Q-linea AB (FRA:3F80) has a Total Operating Expense of kr158.48 Mil as of Jun. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Q-linea AB and its competitors.
Is Q-linea AB's Total Operating Expense too high?
Q-linea AB's current Total Operating Expense is kr158.48 Mil. Overall, Q-linea AB has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Q-linea AB's Total Operating Expense compare to ABT and SYK?
Q-linea AB's Total Operating Expense of kr158.48 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Q-linea AB and its competitors. Q-linea AB's current Total Operating Expense is kr158.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-linea AB stock overvalued right now?
Q-linea AB (FRA:3F80) has a current Total Operating Expense of kr158.48 Mil. The stock's GF Value™ is kr1.69, compared to a current price of kr1.76 — trading 4.1% above its estimated fair value. The current Total Operating Expense is kr158.48 Mil. Q-linea AB's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Q-linea AB (FRA:3F80), the current Total Operating Expense is kr158.48 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Q-linea AB (FRA:3F80) Overvalued in 2026?

Based on GuruFocus' analysis, Q-linea AB stock appears to be overvalued. The current stock price of kr1.76 is trading 4.1% above its estimated GF Value™ of kr1.69.

Key valuation signals for FRA:3F80:

  • Total Operating Expense: kr158.48 Mil
  • GF Value™: kr1.69 vs. price of kr1.76 (4.1% above fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the FRA:3F80 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Q-linea AB Business Description

Other Exchanges QLINEA:Sweden
Address Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
60GF Score

Get the complete analysis for FRA:3F80

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.76
Price
kr1.69
GF Value